These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21678497)

  • 1. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells.
    To KK; Yu L; Liu S; Fu J; Cho CH
    Mol Carcinog; 2012 Jun; 51(6):449-64. PubMed ID: 21678497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
    Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of ABCG2 by romidepsin via the aryl hydrocarbon receptor pathway.
    To KK; Robey R; Zhan Z; Bangiolo L; Bates SE
    Mol Cancer Res; 2011 Apr; 9(4):516-27. PubMed ID: 21357443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
    Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
    Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.
    Ui T; Morishima K; Saito S; Sakuma Y; Fujii H; Hosoya Y; Ishikawa S; Aburatani H; Fukayama M; Niki T; Yasuda Y
    Oncol Rep; 2014 Feb; 31(2):619-24. PubMed ID: 24317439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance.
    Liu L; Zuo LF; Guo JW
    Mol Med Rep; 2014 Apr; 9(4):1299-304. PubMed ID: 24535197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
    Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
    Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein 90 inhibitors suppress aryl hydrocarbon receptor-mediated activation of CYP1A1 and CYP1B1 transcription and DNA adduct formation.
    Hughes D; Guttenplan JB; Marcus CB; Subbaramaiah K; Dannenberg AJ
    Cancer Prev Res (Phila); 2008 Nov; 1(6):485-93. PubMed ID: 19138996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sperm protein 17 is a novel marker for predicting cisplatin response in esophageal squamous cancer cell lines.
    Kausar T; Ahsan A; Hasan MR; Lin L; Beer DG; Ralhan R
    Int J Cancer; 2010 Mar; 126(6):1494-503. PubMed ID: 19685492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2).
    Tan KP; Wang B; Yang M; Boutros PC; Macaulay J; Xu H; Chuang AI; Kosuge K; Yamamoto M; Takahashi S; Wu AM; Ross DD; Harper PA; Ito S
    Mol Pharmacol; 2010 Aug; 78(2):175-85. PubMed ID: 20460431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines.
    Tang Y; Hou J; Li G; Song Z; Li X; Yang C; Liu W; Hu Y; Xu Y
    Oncol Rep; 2014 Nov; 32(5):2168-74. PubMed ID: 25200103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
    Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G
    Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.
    Bram EE; Stark M; Raz S; Assaraf YG
    Neoplasia; 2009 Dec; 11(12):1359-70. PubMed ID: 20019844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells.
    Ke SZ; Ni XY; Zhang YH; Wang YN; Wu B; Gao FG
    Int J Oncol; 2013 Apr; 42(4):1289-96. PubMed ID: 23381786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulus-induced expression of the ABCG2 multidrug transporter in HepG2 hepatocarcinoma model cells involves the ERK1/2 cascade and alternative promoters.
    de Boussac H; Orbán TI; Várady G; Tihanyi B; Bacquet C; Brózik A; Váradi A; Sarkadi B; Arányi T
    Biochem Biophys Res Commun; 2012 Sep; 426(2):172-6. PubMed ID: 22922104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells.
    Tompkins LM; Li H; Li L; Lynch C; Xie Y; Nakanishi T; Ross DD; Wang H
    Biochem Pharmacol; 2010 Dec; 80(11):1754-61. PubMed ID: 20804740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between adenosine triphosphate (ATP)-binding cassette transporter G2 (ABCG2) and drug resistance of esophageal cancer and reversal of drug resistance by artesunate.
    Wang L; Liu L; Chen Y; Du Y; Wang J; Liu J
    Pathol Res Pract; 2018 Sep; 214(9):1467-1473. PubMed ID: 30104076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.